SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from IN8BIO, (INAB) — May 15, 2026

IN8BIO, INC.
Date: May 15, 2026 · CIK: 0001740279 · Accession: 0001193125-26-225869

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-291393

Date
May 19, 2026
Author
Patrick McCall
Form
CORRESP
Company
IN8BIO, INC.

Letter

RE: IN8bio, Inc. Registration Statement on Form S-3 File No. 333-291393 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, IN8bio, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on May 19, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. Once the Registration Statement has been declared effective, please orally confirm that event with Jaime L. Chase at (202) 728-7096 or, in her absence, Trey Reilly of Cooley LLP, counsel to the Registrant, at (212) 479-6502.

IN8bio, Inc. 350 5th Avenue, Suite 5330 New York, New York 10118 May 15, 2026 VIA EDGAR Division of Corporation Finance Office of Technology United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C.

Very truly yours,
IN8bio, Inc.

Show Raw Text
CORRESP
 1
 filename1.htm

 CORRESP

 IN8bio, Inc.
 350 5th Avenue, Suite 5330
 New York, New York 10118 May 15,
2026 VIA EDGAR Division of Corporation
Finance Office of Technology United States Securities and
Exchange Commission 100 F Street, N.E. Washington, D.C.
20549

 RE:
 IN8bio, Inc.
 Registration Statement on Form S-3
 File No. 333-291393
 Ladies and Gentlemen: Pursuant to Rule 461 under the Securities
Exchange Act of 1933, as amended, IN8bio, Inc. (the “ Registrant ”) hereby requests that the U.S. Securities and Exchange Commission (the “ Commission ”) take appropriate action to cause the above-referenced
Registration Statement on Form S-3 to become effective on May 19, 2026, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may
orally request via telephone call to the staff of the Commission. Once the Registration Statement has been declared effective, please orally confirm that
event with Jaime L. Chase at (202) 728-7096 or, in her absence, Trey Reilly of Cooley LLP, counsel to the
 Registrant, at (212) 479-6502.

 Very truly yours,

 IN8bio, Inc.

 By:

 /s/ Patrick McCall

 Name: Patrick McCall

 Title: Chief Financial Officer

 cc:
 William Ho, IN8bio, Inc.
 Jaime L. Chase, Cooley LLP Trey
Reilly, Cooley LLP